Research News and Research

RSS

Research team receives nearly $17M to focus on nanopore technology in DNA sequencing

The use of nanopore technology aimed at more accurate and efficient DNA sequencing is the main focus of grants awarded by the National Institutes of Health. The grants - nearly $17 million to eight research teams - are the latest awarded through the National Human Genome Research Institute (NHGRI)'s Advanced DNA Sequencing Technology program, which was launched in 2004. NHGRI is part of NIH.

7 Sep 2013

State highlights: N.M. high court rules malpractice law covers doc businesses

A selection of health policy stories from Texas, New Mexico, California, South Carolina, Iowa, Florida, Minnesota and Massachusetts.

7 Sep 2013

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

For health exchanges, will soft launches lead to hard landings?

CQ HealthBeat examines whether the new online insurance marketplaces will be ready to go on Oct. 1, and what possible delays might emerge and how those delays could impact the exchanges' effectiveness. Also in the headlines, reports from Delaware, Kentucky, Washington, Pennsylvania, Arizona and Georgia.

7 Sep 2013

Enzymatics buys Boulder-based ArcherDx

Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.

7 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

Effort to fix doc's Medicare pay formula gains momentum

A bill now pending in the House that has cleared the Energy and Commerce Committee would repeal the sustainable growth rate -- SGR -- formula and replace it with a more quality-based system.

7 Sep 2013

FUJIFILM SonoSite gets CE mark approval for X-Porte Ultrasound Kiosk

FUJIFILM SonoSite, Inc., specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced CE mark approval for its newest generation of point-of-care ultrasound: the X-Porte Ultrasound Kiosk.

7 Sep 2013

IRS proposes rules for health law's employer mandate

On Thursday, the Internal Revenue Service published proposed rules for how companies with more than 50 employees must report health coverage for their workers. That provision was delayed a year until 2015.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.

7 Sep 2013

NIH awards nearly $14M grants to research on how genetic factors influence susceptibility to disease

Five research teams have received new four-year awards to study the genomics of disease susceptibility in ethnically diverse populations. The projects aim to unravel the subtle variations in genetic makeup among groups - including African-Americans, Asian-Americans, Hispanics and more - that may account for differences in risks for conditions such as high blood pressure and high blood lipids, in addition to common diseases such as cancer and heart disease.

7 Sep 2013

Abraxane drug gets FDA approval for patients with advanced pancreatic cancer

The U.S. Food and Drug Administration today approved Abraxane for patients with advanced pancreatic cancer, following 7 years of rigorous clinical trials overseen by Scottsdale Healthcare and the Translational Genomics Research Institute.

7 Sep 2013

Saban Research Institute hosted symposium on MUCMD at Children's Hospital Los Angeles

The Saban Research Institute recently hosted the 3rd annual Meaningful Use of Complex Medical Data (MUCMD) Symposium. Organized by Randall Wetzel, MD, chairman of the Department of Anesthesiology and Critical Care Medicine at Children's Hospital Los Angeles, MUCMD is a forum that fosters communication between physicians and "Big Data" experts in order to make use of the large amounts of medical data.

7 Sep 2013

Researchers take detailed images of morphing structure of Parkinson’s protein

Researchers have taken detailed images and measurements of the morphing structure of a brain protein thought to play a role in Parkinson's disease, information that could aid the development of medications to treat the condition.

7 Sep 2013

In states resistant to the health law, poorest residents unlikely to get aid

USA Today reports on how, in states that opted not to pursue the health law's Medicaid expansion, many of the poorest residents may fall through the cracks. Meanwhile, the San Jose Mercury News looks at some of the states that have been the most resistant to implementing the health law.

7 Sep 2013

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.

7 Sep 2013

Researchers find key mechanism behind Alzheimer's disease

Alzheimer's disease affects more than 26 million people worldwide. It is predicted to skyrocket as boomers age-nearly 106 million people are projected to have the disease by 2050.

7 Sep 2013

Basic fibroblast growth factor can protect endplate in motor neurons of injured spinal cord

In current studies, the degeneration and protection measures in the distal end of the injured spinal cord and target organ muscle effector have scarcely been investigated. The distal end of the spinal cord and neuromuscular junction may develop secondary degenera-tion and damage following spinal cord injury because of the loss of neural connections.

7 Sep 2013

Safety and health checklist to help kids avoid emergency room

With the school year underway, Children's Hospital Los Angeles experts have developed a safety and health checklist to help kids avoid the emergency room and develop productive extracurricular and learning activities to enhance the classroom experience. What do parents need to consider? Many symptoms of childhood conditions are often discovered in the classroom.

7 Sep 2013

Research News and Research

Research team receives nearly $17M to focus on nanopore technology in DNA sequencing

State highlights: N.M. high court rules malpractice law covers doc businesses

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

For health exchanges, will soft launches lead to hard landings?

Enzymatics buys Boulder-based ArcherDx

Research roundup: The financial burden of hospital acquired infections

Effort to fix doc's Medicare pay formula gains momentum

FUJIFILM SonoSite gets CE mark approval for X-Porte Ultrasound Kiosk

IRS proposes rules for health law's employer mandate

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

NIH awards nearly $14M grants to research on how genetic factors influence susceptibility to disease

Abraxane drug gets FDA approval for patients with advanced pancreatic cancer

Saban Research Institute hosted symposium on MUCMD at Children's Hospital Los Angeles

Researchers take detailed images of morphing structure of Parkinson’s protein

In states resistant to the health law, poorest residents unlikely to get aid

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

Researchers find key mechanism behind Alzheimer's disease

Basic fibroblast growth factor can protect endplate in motor neurons of injured spinal cord

Safety and health checklist to help kids avoid emergency room

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery